$2.51
Live
2.39%
Downside
Day's Volatility :6.26%
Upside
3.97%
21.18%
Downside
52 Weeks Volatility :35.98%
Upside
18.77%
Period | Koru Medical Systems Inc | Index (Russel 2000) |
---|---|---|
3 Months | -0.76% | 0.0% |
6 Months | 22.54% | 0.0% |
1 Year | 9.21% | 0.0% |
3 Years | -0.76% | -23.0% |
Market Capitalization | 116.9M |
Book Value | $0.41 |
Earnings Per Share (EPS) | -0.25 |
Wall Street Target Price | 3.6 |
Profit Margin | -38.16% |
Operating Margin TTM | -14.14% |
Return On Assets TTM | -14.1% |
Return On Equity TTM | -50.25% |
Revenue TTM | 30.8M |
Revenue Per Share TTM | 0.67 |
Quarterly Revenue Growth YOY | 21.5% |
Gross Profit TTM | 15.4M |
EBITDA | -6.2M |
Diluted Eps TTM | -0.25 |
Quarterly Earnings Growth YOY | -0.66 |
EPS Estimate Current Year | -0.14 |
EPS Estimate Next Year | -0.09 |
EPS Estimate Current Quarter | -0.04 |
EPS Estimate Next Quarter | -0.04 |
What analysts predicted
Upside of 43.43%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 17.4M | ↑ 12.37% |
Net Income | 910.6K | ↑ 11.11% |
Net Profit Margin | 5.25% | ↓ 0.06% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 23.2M | ↑ 33.47% |
Net Income | 564.3K | ↓ 38.02% |
Net Profit Margin | 2.44% | ↓ 2.81% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 24.2M | ↑ 4.38% |
Net Income | -1.2M | ↓ 314.77% |
Net Profit Margin | -5.01% | ↓ 7.45% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 23.5M | ↓ 2.84% |
Net Income | -4.6M | ↑ 276.45% |
Net Profit Margin | -19.42% | ↓ 14.41% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 27.9M | ↑ 18.76% |
Net Income | -8.7M | ↑ 89.82% |
Net Profit Margin | -31.05% | ↓ 11.63% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 28.5M | ↑ 2.23% |
Net Income | -13.7M | ↑ 58.65% |
Net Profit Margin | -48.18% | ↓ 17.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 7.4M | ↑ 0.65% |
Net Income | -2.4M | ↑ 21.96% |
Net Profit Margin | -32.61% | ↓ 5.7% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 6.9M | ↓ 6.18% |
Net Income | -2.5M | ↑ 3.53% |
Net Profit Margin | -35.98% | ↓ 3.37% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 7.0M | ↑ 0.97% |
Net Income | -1.4M | ↓ 45.18% |
Net Profit Margin | -19.54% | ↑ 16.44% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 7.2M | ↑ 2.61% |
Net Income | -7.5M | ↑ 445.66% |
Net Profit Margin | -103.9% | ↓ 84.36% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 8.2M | ↑ 14.08% |
Net Income | -1.9M | ↓ 74.07% |
Net Profit Margin | -23.62% | ↑ 80.28% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 8.4M | ↑ 2.83% |
Net Income | -988.7K | ↓ 48.93% |
Net Profit Margin | -11.73% | ↑ 11.89% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 10.5M | ↑ 13.62% |
Total Liabilities | 1.6M | ↓ 1.67% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 13.9M | ↑ 31.64% |
Total Liabilities | 2.6M | ↑ 67.01% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 39.9M | ↑ 187.56% |
Total Liabilities | 3.8M | ↑ 42.19% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 41.3M | ↑ 3.44% |
Total Liabilities | 4.8M | ↑ 27.38% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 42.3M | ↑ 2.52% |
Total Liabilities | 11.0M | ↑ 129.69% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 28.5M | ↓ 32.77% |
Total Liabilities | 8.1M | ↓ 26.34% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 38.3M | ↓ 9.63% |
Total Liabilities | 8.5M | ↓ 23.16% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 36.0M | ↓ 5.9% |
Total Liabilities | 7.9M | ↓ 6.65% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 35.4M | ↓ 1.78% |
Total Liabilities | 7.9M | ↑ 0.37% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 28.5M | ↓ 19.5% |
Total Liabilities | 8.1M | ↑ 2.32% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 27.5M | ↓ 3.37% |
Total Liabilities | 8.4M | ↑ 3.4% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 27.3M | ↓ 0.72% |
Total Liabilities | 8.6M | ↑ 2.58% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.5M | ↑ 64.42% |
Investing Cash Flow | -1.7M | ↑ 557.39% |
Financing Cash Flow | 14.4K | ↓ 174.53% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 320.6K | ↓ 78.33% |
Investing Cash Flow | 1.3M | ↓ 175.74% |
Financing Cash Flow | 501.3K | ↑ 3374.23% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -743.3K | ↓ 331.84% |
Investing Cash Flow | -1.0M | ↓ 179.08% |
Financing Cash Flow | 23.2M | ↑ 4532.75% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -4.3M | ↑ 481.11% |
Investing Cash Flow | -366.2K | ↓ 64.66% |
Financing Cash Flow | 2.7M | ↓ 88.35% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -5.4M | ↑ 25.12% |
Investing Cash Flow | -2.8M | ↑ 665.1% |
Financing Cash Flow | 279.5K | ↓ 89.67% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -4.7M | ↓ 448.72% |
Investing Cash Flow | -283.8K | ↑ 26.79% |
Financing Cash Flow | -239.0K | ↑ 64.13% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -153.9K | ↓ 96.7% |
Investing Cash Flow | -108.7K | ↓ 61.7% |
Financing Cash Flow | -242.8K | ↑ 1.61% |
Sell
Neutral
Buy
Koru Medical Systems Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Koru Medical Systems Inc | -2.61% | 22.54% | 9.21% | -0.76% | -33.92% |
Intuitive Surgical, Inc. | 6.56% | 41.26% | 91.18% | 53.45% | 177.85% |
Resmed Inc. | -2.51% | 33.07% | 63.68% | -8.76% | 83.88% |
Becton, Dickinson And Company | 3.84% | 4.22% | -4.76% | -1.1% | -4.07% |
Alcon Ag | -2.89% | 18.03% | 30.76% | 16.68% | 62.63% |
Cooper Companies Inc., The | -1.41% | 20.24% | -66.42% | 5.22% | 50.71% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Koru Medical Systems Inc | NA | NA | NA | -0.14 | -0.5 | -0.14 | NA | 0.41 |
Intuitive Surgical, Inc. | 81.54 | 81.54 | 4.08 | 6.65 | 0.16 | 0.08 | NA | 41.4 |
Resmed Inc. | 34.67 | 34.67 | 2.0 | 7.71 | 0.23 | 0.13 | 0.01 | 33.11 |
Becton, Dickinson And Company | 48.07 | 48.07 | 1.11 | 13.11 | 0.06 | 0.03 | 0.02 | 89.5 |
Alcon Ag | 42.58 | 42.58 | 3.58 | 3.06 | 0.05 | 0.03 | 0.0 | 42.35 |
Cooper Companies Inc., The | 59.32 | 59.32 | 11.0 | 3.66 | 0.05 | 0.03 | NA | 39.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Koru Medical Systems Inc | Buy | $116.9M | -33.92% | NA | -38.16% |
Intuitive Surgical, Inc. | Buy | $168.3B | 177.85% | 81.54 | 27.65% |
Resmed Inc. | Buy | $35.2B | 83.88% | 34.67 | 21.79% |
Becton, Dickinson And Company | Buy | $69.5B | -4.07% | 48.07 | 7.13% |
Alcon Ag | Buy | $46.6B | 62.63% | 42.58 | 11.44% |
Cooper Companies Inc., The | Buy | $21.3B | 50.71% | 59.32 | 9.45% |
Insights on Koru Medical Systems Inc
Revenue is up for the last 5 quarters, 6.93M → 8.43M (in $), with an average increase of 4.7% per quarter
Netprofit is up for the last 3 quarters, -7.46M → -988.71K (in $), with an average increase of 190.7% per quarter
In the last 1 year, Intuitive Surgical, Inc. has given 95.3% return, outperforming this stock by 84.7%
In the last 3 years, Intuitive Surgical, Inc. has given 53.4% return, outperforming this stock by 54.2%
First Light Asset Management, LLC
Vanguard Group Inc
Archon Capital Management LLC
Meros Investment Management, LP
RBF LLC
Albion Financial Group (Utah)
repro medsystems inc is a company based out of 24 carpenter road, chester, new york, united states.
Organization | Koru Medical Systems Inc |
Employees | 82 |
CEO | Ms. Linda M. Tharby |
Industry | Health Technology |
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$2.51
-3.83%
Invesco Bulletshares 2025 Hi
$2.51
-3.83%
Schwab International Dividend Equity Etf
$2.51
-3.83%
Blockchain Coinvestors Acquisition Corp.
$2.51
-3.83%
Allgiant Travel Company
$2.51
-3.83%
Rogers Corp
$2.51
-3.83%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$2.51
-3.83%
Iheartmedia
$2.51
-3.83%
Lightpath Technologies Inc
$2.51
-3.83%